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ABSTRACT 
Osteoarthritis (OA) is a debilitating disease marked by changes in cartilage and 
subchondral bone, but symptomatically marked by pain. Pain pathophysiology is poorly 
understood, but as patellar subchondral bone is innervated, it could be linked to OA-related knee 
pain. Also, subchondral cortical and trabecular bone may each play individual roles in OA-
related pain pathophysiology.  
 The overall goal of this study was to determine how subchondral bone is related to pain 
in OA. The objectives of this study were 1) to measure to in vivo precision of computed 
tomography topographic mapping of subchondral density (CT-TOMASD) in the patella, and to 
2) to apply CT-TOMASD to a clinical sample to determine if there were differences in patellar 
subchondral bone density between knee OA patients with different pain experiences. 
 In vivo precision (CV%RMS) of CT-TOMSAD in the patella ranged from 1.1% to 6.8%. 
Precision errors were approximately 4 times greater than observed BMD differences between 
healthy and OA groups. 
 In the clinical analysis, participants with ‗severe pain at rest‘ had 16% lower BMD over 
the total lateral patellar facet at depths of 5-7.5mm from the subchondral surface than 
participants with ‗non-severe pain at rest‘. Regional analysis showed that participants with 
‗severe pain at rest‘ had lower BMD in the inferior lateral facet; 13% at the 0-2.5mm depth, 23% 
at the 2.5-5mm depth, and 22% at the 5-7.5mm depth.  
 This is the first study to report QCT-based subchondral cortical and trabecular BMD 
values in the patella. This is also the first application of CT-TOMASD to a sample of 
participants with clinically diagnosed OA; and the first study to report relationships between 
BMD and pain, showing that trabecular bone changes may be related to pain.  
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radiograph 
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CHAPTER  1 
OVERVIEW 
1.1. Introduction 
Osteoarthritis (OA) is a debilitating and painful disease characterized by joint surface cartilage 
degeneration [1-3]. Although cartilage degeneration is the most apparent characteristic of OA, 
changes in underlying bone immediately below cartilage (subchondral bone) have been proposed 
to influence and accelerate cartilage degeneration [4]. Subchondral bone changes are a prominent 
risk factor of OA, resulting from changes to the biomechanical loading environment within the 
affected joint [2, 5, 6]. Bone mineral density (BMD) is a surrogate measure of mechanical 
properties [2, 7] and can be measured using various imaging techniques. 
 Pain is the dominant symptom in OA, and is typically measured using the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) [8]. Pain is also the primary 
focus of most treatment strategies [9], including prioritizing for joint replacement [10]. 
Unfortunately, pain may not necessarily be present in early stages of OA [11-13], making patient 
self-identification difficult [14]. The relationship between pain and radiographic OA is 
complicated as they are poorly related in mild OA, but more strongly related in severe OA [11]. 
In some cases radiographic OA may be present without symptoms, or vice versa where 
symptoms are present but without evidence of radiographic changes associated with OA [15].  
 The patellofemoral (PF) compartment is involved in 50% to 65% [16, 17] of clinically 
diagnosed OA cases and is highly likely to be related to pain [12, 18]. Subchondral bone is 
innervated (highly supplied with nerves) [19, 20] and could be a potential source of pain in OA 
[21], as opposed to aneural and insensate cartilage [22].  
 It may be possible to learn more about the role of subchondral bone in OA progression 
and identify links between subchondral bone properties, such as BMD, and OA-related 
symptoms, such as pain, using in vivo imaging. However, current imaging tools are poorly suited 
for analyzing three-dimensional BMD in the patella. Computed tomography topographic 
mapping of subchondral density (CT-TOMASD) has been recently developed by Johnston et al. 
[23] and used to precisely measure subchondral bone density of the proximal tibia in cadaveric 
[24, 25] and in vivo studies [26]. These early studies show the potential to use CT-TOMASD to 
measure subchondral bone density of other similar articulating surfaces, such as the patella.  
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 This research assessed the potential use of CT-TOMASD in the patella by measuring the 
repeatability of density measures through a precision study. With repeatable density measures, 
CT-TOMASD was then used to measure subchondral BMD in a sample of individuals with 
clinically diagnosed OA. Relationships between BMD and OA-related pain at rest (using 
WOMAC) were evaluated.  
 
1.2. Scope 
Chapter 2 provides a review of literature to date. Chapter 3 includes my research questions and 
project objectives. Chapter 4 outlines the short-term in vivo precision analysis of CT-TOMASD 
in the patella in patients with and without OA as well as the CT-TOMASD process in detail. 
Chapter 5 describes our study comparing patellar BMD between participants with clinically 
diagnosed OA experiencing ‗severe pain at rest‘ and ‗non-severe pain at rest‘. Chapter 6 reviews 
the conclusions of this research and offers recommendations for future studies.    
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CHAPTER  2 
LITERATURE REVIEW 
2.1 Anatomy 
2.1.1. Knee Joint  
The knee joint consists of three bones: the proximal tibia, the distal femur and the patella, and 
two distinct articulating joints: the patellofemoral (PF) joint and the tibiofemoral (TF) joint 
(Figure 2-1). The TF joint allows for flexion and extension of the leg. The PF joint guides the 
line of action of extensor muscles in the leg along the trochlear grove, maintaining a vertical 
force through the femur [27]. The primary area of interest for this study is the PF joint, which is 
affected in 50% to 65% of OA cases [16, 17].  
 
Figure 2-1. Anterior (A) and side (B) views of the knee joint, showing patellofemoral (PF) and 
tibiofemoral (TF) joints. Patella and quadriceps tendon removed (C) to expose trochlear groove. 
2.1.2. The Patella and Patellofemoral (PF) Joint 
The patella is a large sesamoid bone embedded within the quadriceps tendon that articulates in 
the trochlear grove on the anterior side of the distal femur. The patella acts as a fulcrum of a 
lever as the knee flexes and extends increasing the moment arm of the quadriceps muscle as it 
travels along the trochlear groove (Figure 2-1C) [28]. 
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Figure 2-2. Diagram of patellar contact regions while in deep flexion (A) and in neutral 
alignment (B).  Patella contact regions are emphasized by thickened areas. 
The patella and the PF joint play an important role in force and load distribution through 
the knee joint, with the patella capable of sustaining loads up to eight times body weight during 
deep knee bends [29]. Depending on the degree of flexion in the knee, patellar surface contact 
regions with the distal femur will range from the superior region of the patella in deep flexion 
(Figure 2-2A) to the inferior region of the patella in neutral alignment (Figure 2-2B) [27].  
The articulating surface (anterior face) of the patella consists of the medial and lateral 
facets, divided by the transverse ridge (Figure 2-3). The lateral patellar facet has 60% more force 
applied from the quadriceps muscles than the medial facet [30], and bears more stress (pressure) 
than the medial patellar facet from mid flexion to full knee extension [31].  
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Figure 2-3. Diagram of articulating surface of the patella (lateral facet in blue, medial facet in 
red). 
2.1.3. Articular Cartilage 
The joint surfaces of each bone in the knee are covered with articular cartilage (Figure 2-4), a 
flexible connective tissue that serves as a low friction bearing material and allows transmission 
of loads between surfaces. Cartilage is avascular, aneural [19, 20], and insensate [22], therefore 
has a weak regeneration ability. Typical cartilage thickness in the healthy patella can range from 
3mm to 5mm [32, 33]. 
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Figure 2-4. Schematic diagram of the layers in the subchondral bone region showing articular 
cartilage, subchondral cortical bone and subchondral trabecular bone. 
2.1.4. Subchondral Bone 
The region directly inferior to articular cartilage is comprised of various layers of tissues: 
 tidemark; noting the division between articular cartilage and bony subchondral tissues 
(Figure 2-4); 
 calcified cartilage; poorly mineralized tissue, ranging from 23 µm to 230µm [34], 
associated with subchondral cortical bone (Figure 2-4); 
 subchondral cortical bone or subchondral endplate; thin highly mineralized layer of bone 
tissue (bone mineral density (BMD) > 400 mg/cm
3
) [35] (Figure 2-4); 
 subchondral trabecular bone; also known as cancellous bone, more porous tissue that acts 
as a support to overlying subchondral cortical bone (BMD < 400 mg/cm
3
) [35] (Figure 2-
4).  
―Subchondral bone‖ is a term used to describe the subchondral structure, including subchondral 
cortical and subchondral trabecular bone and acts as the joint‘s primary supportive structure and 
energy-transferring source [36]. Subchondral bone and cartilage both play a role in the 
development and pathogenesis of OA, but distinct mechanical changes at various stages of 
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disease progression remain unknown. A current hypothesis in OA initiation and progression 
poses that as the rate of bone turnover increases, through the adaptive nature of bone modeling, 
the subchondral plate thickens and stiffens, disrupting the mechanical environment, leading to 
cartilage damage [1, 4, 37].  
 
2.2. Osteoarthritis  
Osteoarthritis affects approximately 85% of the Canadian population over 75 years of age [38], 
with knee OA being the most common form of clinically diagnosed OA [39]. OA is commonly 
thought as primarily affecting the TF joint, often overlooking the PF joint [40-42]. In the 
Framingham Osteoarthritis Study, radiographs from 1420 participants were evaluated with 
32.9% showing evidence of radiographic OA, 15.7% showing evidence of radiographic changes 
leading to increased OA severity, and 9.5% showing evidence of symptomatic OA [43]. From 
the UK-based Knee Clinical Assessment Study, a group of 777 individuals expressing knee pain 
were classified based on radiographic assessment, with 68% showing no evidence of OA, 31% 
showing evidence of TF OA, 40% having combined (PF and TF) OA, and 24% showing only 
evidence of PF OA [17]. Although the TF joint tends to be the most evaluated in clinical studies 
[40], in this study half of the participants with OA showed evidence of radiographic OA in the 
PF joint.  
 
2.2.1. Risk Factors  
A wide range of research exploring OA risk factors exists, yet very little is understood about the 
primary ―cause‖ of OA. Some known risk factors include systemic and biomechanical factors, 
such as hormonal status, bone metabolic biomarkers, joint mechanical environment, obesity, 
joint injury, joint alignment, age, sex, and bone mineral density (BMD) [44]. It is very likely that 
disease onset and progression is a result of a combination of these elements, and treatment 
strategies typically incorporate a variety of methods that target many risk factors [9].  
 Of interest to this project, multiple imaging studies have shown relationships between 
BMD and OA [44, 45]. Higher BMD may be associated with denser, stiffer bone, which may 
lead to increased mechanical stress in cartilage during joint loading, cartilage damage, and 
increased risk of OA [2]. A large study, once again using the Framingham OA cohort, found that 
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mean femoral BMD was higher in women with mild OA, but lower in women with severe OA 
[46]. Other studies have found similar relationships [47, 48], supporting that high BMD is 
associated with an increased risk of OA. Studies show that subchondral bone changes are related 
to cartilage degeneration [49, 50] or pain [51-54], but the relationship between disease 
progression and BMD is currently unknown. As BMD is related to mechanical properties [2, 7], 
it may be useful in understanding the relationship between disease progression and OA; BMD 
can also be easily monitored and measured using various imaging tools.  
 
2.2.2. Disease Characteristics 
Osteoarthritis can be characterized through clinical symptoms, morphological changes in the 
joint environment, or biomechanical alterations. Clinically, OA is a disease characterized by 
pain, joint dysfunction, limited motion, possible swelling, stiffness, and radiological evidence 
such as osteophyte presence (bony projection along joint margin), joint space narrowing, and 
sclerosis (regional bone tissue hardening) (Figure 2-5) [5, 6, 44, 55]. Morphological joint 
changes associated with OA may include articular cartilage loss; subchondral bone changes 
including sclerosis, cysts, bone marrow lesions, or attrition; osteophyte presence; and synovial 
inflammation [5, 37, 44, 55, 56]. Biomechanically, OA is characterized through the process of a 
failed repair of joint damage potentially caused by mechanical or loading changes within the 
joint [37, 55, 57], where changes may include altered loading patterns or changes in cartilage or 
subchondral bone mechanical properties (e.g., stiffness, strength, geometry).  
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Figure 2-5. Representative radiographs of normal (left) and OA (right) knees.  Note the evidence 
of osteophytes, joint space narrowing and sclerosis in the OA joint on the right. 
2.2.3. Clinical Classification 
Clinical classification of OA can be divided into two cases: a) radiographic OA or b) 
symptomatic OA. Radiographic OA occurs when evidence of radiographic changes (osteophytes, 
joint space narrowing, sclerosis, and subchondral cysts) are present in a clinical evaluation. 
Symptoms (pain, stiffness, loss of function, alteration in joint shape, inflammation) may or may 
not be present in all cases of radiographic OA [15]; but symptomatic OA may be present in the 
absence of radiographic joint changes [15]. For example, in a population study of 6880 
individuals, 14.6% reported symptomatic knee pain, 3.7% exhibited evidence of radiographic 
OA, and 25.6% reported arthritis at any joint site (Figure 2-6) [15]. Of the individuals that 
exhibited radiographic OA, only 47% reported clinical OA symptoms. But, in those who 
reported OA symptoms, only 15% showed evidence of radiographic changes. To complicate the 
matter, of those with self-reported OA, 11% showed evidence of radiographic changes, and 34% 
showed OA symptoms.  
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Figure 2-6. Proportions of radiographic OA, symptomatic knee pain and self-reported OA in 
National Health and Nutrition Examination Survey I study (adapted from Hannan 2000 [15]). 
2.2.3.1. Radiographic measures 
The most common clinical measure to determine radiographic knee OA severity is the Kellgren-
Lawrence (KL) scoring system [58] (Table 2-1). The KL system uses qualitative and subjective 
radiographic evidence to assess radiographic OA severity through evidence or presence of 
osteophytes, joint space narrowing (JSN), sclerosis (elevation of bone density), joint deformity, 
and bony attrition. A knee with a score of 0 shows no radiographic indication of OA, a score of 
1-2 indicates mild OA, and a score of 3-4 indicates moderate to severe OA.   
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Table 2-1. Kellgren-Lawrence [58] scoring system for OA severity based on radiographic 
evidence.  
Grade Qualifier Radiographical features 
0 None Normal, no osteophytes, no evidence of OA 
1 Doubtful Possible osteophytic lipping 
2 Minimal Definite osteophytes, possible joint space narrowing 
3 Moderate 
Multiple or moderate osteophytes, definite joint space narrowing, 
evidence of sclerosis, possible deformity of bone ends, possible 
bony attrition 
4 Severe 
Large osteophytes, marked joint space narrowing, severe 
sclerosis, definite deformity of bone ends, definite bony attrition 
 
 Another lesser used technique to determine radiographic OA severity is through the use 
of the Osteoarthritis Research Society International Radiographic Atlas (OARSI Atlas) [59]. This 
scoring system uses similar qualitative evidence as the KL system, but focuses on other PF joint-
specific evidence of OA such as patellar subluxation—lateral tilt as presented on a skyline 
radiograph. This technique provides a scoring system for a variety of radiographic signs of OA 
and can be used to score single specific qualities, such as only JSN or only sclerosis. This 
flexibility allows for multiple uses of the OARSI Atlas within a study, as joints can be qualified 
in different severity categories depending on evidence of different OA-related qualities. For 
example, a skyline PF radiograph may show evidence of moderate lateral osteophytes, scoring a 
grade 2, but may have severe sclerosis, scoring a grade 3. This complexity is useful for clinical 
studies and research where evidence of distinct characteristics of OA may be necessary.  
 
2.2.3.2. Symptomatic measures 
Common symptoms of OA are joint pain, stiffness, reduced mobility, depression, and anxiety; 
with the most prevalent being joint pain and stiffness [9]. Pain is the dominant symptom of OA, 
unique to each patient and is difficult to quantify, creating frustration from both the patient‘s and 
physician‘s perspectives [13]. Pain is also the primary focus of most treatment strategies [9], 
including joint replacement prioritization [60]. Unfortunately, pain may not necessarily be 
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present in early stages of OA [11, 12], thus joint degeneration may already be present within the 
knee before the patient seeks medical consult [14].  
 Pain is a subjective and patient-specific experience. A focus group evaluating chronic 
knee and hip pain of 28 participants showed certain themes and similarities in their pain 
experiences [13]. Pain was intermittent and variable, with patients expressing that pain could 
change from month-to-month or from day-to-day. Other similarities included pain present with 
function, movement, activities, or body positioning; especially at night while in bed [13].  
 Pain while sleeping, or nocturnal pain, is a particularly common concern among OA 
patients as it is most often unpredictable [61] and disturbs sleep quality, thus disturbing quality 
of life [62]. To relieve pain, participants most often changed sleeping position for temporary 
relief, but most sought relief with pain medications.  
 The most common questionnaire used to quantify pain is the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) [8]. The WOMAC questionnaire [8, 63] 
has 24 parameters in three subsections: pain, stiffness, and physical function (Table 2-2). The 
pain subsection is used to quantify the patient pain experience while walking, climbing stairs, 
lying down, sitting, and standing. The stiffness subsection measures morning joint stiffness and 
stiffness occurring during the day. The more involved physical function subsection asks the 
patient to assess the amount of difficulty they experience when performing daily activities, e.g., 
walking up stairs, walking down stairs, putting on socks, bending to the floor, and rising from 
bed. Patient responses are based on a 5-pt Likert scale (Table 2-3) where 0 represents no pain, 
stiffness, or functional difficulty within the past 48 hours. Scores of 1 through 4 represent mild, 
moderate, severe, and extreme pain, stiffness, or difficulty respectively. Pain, stiffness, and 
functionality subsections can be used independently or collectively.  
For specific assessment of nocturnal pain (or pain at rest), the WOMAC pain subscale 
can be divided into various groupings dependent on common traits: weight-bearing activities 
(walking and up/down stairs) and non-weight bearing activities (sitting and laying down) [64].  
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Table 2-2. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 
questionnaire subsections with corresponding question elements.  
Subsection Question elements 
Pain Walking, Up/down stairs, Lying in bed, Sitting, Standing 
Stiffness Morning stiffness, Stiffness later in day 
Physical Function Descending stairs, Ascending stairs, Rising from sitting,  
Standing, Bending to the floor, Walking on a flat surface,  
Getting in/out of car, Going shopping, Putting on socks or shoes, 
Rising from bed, Taking off socks or shoes, Lying in bed,  
Getting in/out of the bath, Sitting, Getting on/off the toilet, 
Performing heavy domestic duties, Performing light domestic 
duties 
Table 2-3. Scoring and interpretation values of the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC).   
Response Score 
None 0 
Mild (or slight) 1 
Moderate 2 
Severe 3 
Extreme 4 
 
2.2.4. Relationships Between Clinical and Symptomatic OA 
Multiple radiographic features have been related to knee pain [11, 12, 65-67]. Osteophytes in the 
PF joint are reported as the best radiological predictors of pain (odds ratio: 5.57, 95% confidence 
interval (CI): 2.72 to 11.4, p<0.05 [66]; and odds ratio: 2.25, 99%CI: 1.06 to 4.77, p<0.005 
[67]). Joint space narrowing (JSN) is also reported to be significantly related OA-related pain in 
cases with severe to extreme OA [11, 65]. Duncan et al. [12] reported that increasing 
radiographic severity using KL scores is associated with increasing WOMAC pain scores. Pain 
and radiographic evidence are poorly related in cases with mild OA, but more strongly related in 
severe OA cases (odds ratio: 1.5, 95%CI: 0.9 to 2.3, p<0.001 for KL of 1; and odds ratio: 151, 
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95%CI: 43 to 526, p<0.001 for KL of 4 [11]), making patient self-identification difficult [14] as 
pain may not be present in early stages of OA even though radiographic evidence of joint 
changes may be present [68].  
 Each of these studies have found promising evidence relating knee pain and radiographic 
features, but with inconsistent outcomes. Individual features may be related to pain, but in the 
most severe cases intense pain is related to the severity score of the entire knee. This could be 
due to the subjective and patient-specific nature of pain, or could be due to multiple factors in 
OA pain pathogenesis.  
 
2.3. OA-related Pain 
The source of OA-related pain is not well understood as it could be the result of multiple factors, 
and likely in combination [14]. From a biological perspective, neural activity within the pain 
pathway is responsible for the generation, and ultimate manifestation, of joint pain. Normal joint 
tissues tend to be insensitive to pain, possibly because a low pain threshold would result in all 
normal movements to be painful [5]. Pain in OA-affected tissues could be biomechanically 
related and due to local changes in pain pathways, causing normal function and stimuli to 
become painful [5].  
 
2.3.1. Pain Pathogenesis 
OA-related pain could be due to abnormal joint biomechanics [5, 6]. One theory proposes that a 
major component in the OA process is an adaptation mechanism within the afflicted joint, 
through subchondral bone remodeling, to compensate for biomechanical abnormalities (Figure 2-
7) [6]. In this model, the joint attempts to regulate abnormal biomechanics through joint 
remodeling and subchondral bone changes. If abnormal biomechanics are successfully 
controlled, the joint self-stabilizes; if abnormal biomechanics are not successfully controlled, 
then the joint continues to go through the bone remodeling process in an attempt to alter joint 
shape. Joint repair depends largely on the response and remodeling of subchondral bone; with 
increased bone turnover potentially increasing joint pain [6, 69].  
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Figure 2-7. Schematic diagram of a hypothetical process of pain pathogenesis and joint 
remodeling, emphasizing that subchondral bone remodeling could be the primary source of OA-
related pain. In this model, the joint attempts to regulate abnormal biomechanics through joint 
remodeling and subchondral bone changes. If abnormal biomechanics are successfully 
controlled, the joint self-stabilizes; if abnormal biomechanics are not successfully controlled, 
then the joint continues to go through bone remodeling, in an attempt to alter joint shape. Joint 
repair depends largely on the response and remodeling of subchondral bone; with increased bone 
turnover potentially increasing joint pain (adapted from Dieppe 1999 [6]).  
2.3.2. PF Joint and Pain 
The PF joint is strongly associated with OA-related pain [70], and even more frequently related 
to pain than the more explored TF joint [12]. Mild isolated PF OA is significantly associated 
with pain and limited joint function (combined WOMAC baseline pain score of 6.10 compared 
to 3.39 for mild isolated TF OA) [12]. Although the PF joint is involved in 50% to 65% of 
diagnosed cases of OA [16, 17], it is commonly overlooked in OA research [40]. Patellar 
malalignment is commonly present in patients with PF OA [71], has been identified as a risk 
factor for PF OA progression [41], and is commonly addressed as a site for short-term pain relief 
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through bracing or taping [72]. These methods may be successful in the short-term, but the 
reason for their success is still misunderstood, possibly due simply to a lack of investigation of 
the PF joint in OA.  
 Perhaps the primary reason for the lack of PF OA research is related to the anatomy and 
location of the PF joint. It is specifically difficult to acquire a comprehensive image of the PF 
region through the use of traditional radiographs. Clinical examination of the patella and PF 
region is typically through palpation [73], which can be a painful experience and does not 
provide a complete assessment of the PF environment as many OA-associated features (e.g., 
osteophytes) are not directly detectable. Standardized positioning to acquire diagnostic two-
dimensional (2D) radiographs of the patella [74] are suitable for simple diagnosis, but are still 
limiting in that they do not offer a full representation of all surfaces, particularly articulating 
surfaces, of the patella.  
 
2.3.3. Subchondral Bone and Pain 
As previously mentioned, subchondral bone is densely innervated [19, 20, 22], with subchondral 
trabecular bone being more densely innervated than subchondral cortical bone [75]. OA-related 
subchondral bone changes, such as bone marrow lesions (BML), attrition, and intraosseous 
pressure have all shown potential correlations with pain.  
 
2.3.3.1 Pain and bone marrow lesions 
Bone marrow edemas, or bone marrow lesions (BML), are indicated by increased signal in the 
bone marrow on fat-suppressed T2-weighted magnetic resonance images (MRI) [76, 77] and are 
therefore only visible through the use of MRI. Multiple studies have shown promising 
relationships between BML presence and knee pain [52, 53, 77-79]; as well as BML and less 
mineralized subchondral tissue [80]. Although this promising evidence suggests subchondral 
bone is strongly related with joint pain, bone marrow lesions are dynamic and have been 
observed to change over time as OA progresses [50, 67, 81].  
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2.3.3.2. Pain and bone attrition 
Another subchondral bone change associated with pain is bone attrition, defined as either loss of 
bone or as flattening or depression of the articular cortex [54, 82]. Current literature on bone 
attrition is sparse, possibly because traditional OA diagnosis is based on the opposite of attrition, 
i.e., based upon subchondral bone sclerosis or thickening. Two studies have found relationships 
between bone attrition and pain, specifically nocturnal pain, with results that were not significant 
but noteworthy [54, 82]. These findings showed that bone attrition was more frequent among 
painful knees than among knees without pain; also that attrition was present in the absence of 
radiographic OA. Evidence also exists relating BML to bone attrition, showing that local BMD 
within the BML is reduced and may compromise the local mechanical integrity of bone at the 
joint surface, possibly leading to attrition [80].  
 
2.3.3.3. Pain and intraosseous pressure 
A third, lesser explored, subchondral bone change associated with pain is intraosseous 
hypertension [83-85]. One current hypothesis is built on mechanically-based principles where, 
although bone volume remains constant, joint loading energy is transmitted through the cartilage 
and cortical layers to the trabecular bone, which serves as a series of springs accepting and 
distributing the loading energy [84]. Changes to the overlying cartilage and subchondral layers 
will compromise the energy-absorbing ability of the trabecular bone, leading to intra-trabecular 
tension, local intraosseous pressure changes, resulting in pain [83]. Because it is very difficult to 
measure intraosseous pressure without compromising the joint environment, studies investigating 
this hypothesis to pain are few, but promising results show that elevated intraosseous pressure is 
present in patients expressing pain associated with advanced OA [85].  
 
2.3.3.4. Pain and BMD 
Although not yet shown to be significantly related to pain, BMD is another subchondral bone 
change associated with OA and a representative measure of bone strength [86]. BMD can be 
precisely measured, quantified, and compared using multiple imaging modalities. Different 
stages of disease progression have shown varying changes and outcomes in BMD, with some 
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studies reporting higher BMD in patients with OA [87], and other studies reporting lower BMD 
[88], thus the effect of OA on BMD still remains unclear. Also, because BMD is an indirect 
measure of the mechanical properties of bone, the resulting changes in BMD may be joint-
specific as loading patterns differ between joint surfaces, particularly in the PF joint. Studying 
BMD changes may help in understanding why the relationship between radiographic evidence of 
OA and pain is still currently misunderstood. BMD may potentially be a better predictor of OA 
symptoms, because it can be precisely measured and monitored before radiographic or 
symptomatic evidence of OA is present.  
 
2.4. Imaging Techniques 
2.4.1. Radiography 
The current imaging technique to diagnose PF OA consists of standardized two-dimensional 
(2D) radiographs in skyline (or axial) views (Figure 2-8) [66, 74, 89, 90] as it provides the most 
information about the PF joint in 2D space. This radiograph must be taken in weight-bearing 
position with the knee flexed at 30° in order to accurately assess joint space. Although this 
method has been extensively validated [89], even a 2° change in x-ray tube alignment can cause 
an over- or under-measurement in joint space narrowing of up to 1mm. This difference in joint 
space measurement could change the KL score, which could lead to misclassification and 
mistreatment [91]. Additional radiographs, including lateral and posteroanterior views, may be 
helpful in identifying compartmental distribution of OA between the TF and PF joints [17].  
19 
 
Figure 2-8. Patient positioning for standardized skyline radiographic view of patellofemoral 
joint (left) with resulting projection image (right). The patient places their foot on the detector 
film and with the aid of a support frame, bends their knee to 30°.  The X-ray tube and cassette 
are placed directly above the patient‘s head [89].  
Although radiographs are able to measure sizeable joint changes, it is not possible to 
clearly view changes in subchondral bone, such as BMD, which could be present using other 
imaging modalities such as dual-energy x-ray absorptiometry (DXA) [46-48, 51, 92-95], 
computed tomography (CT) [7, 23, 24, 26, 33, 96, 97], or magnetic resonance imaging (MRI) [7, 
96, 98]. Apparent BMD as measured through these techniques is generally regarded as a 
surrogate measure of bone mechanical properties (e.g., stiffness, strength). Although it is 
possible to measure subchondral BMD with any of the listed methods, each has certain strengths 
and limitations, which need to be individually considered.  
 
2.4.2. Dual-Energy X-ray Absorptiometry (DXA or DEXA) 
Dual-energy X-ray absorptiometry (DXA) is a 2D projection-based imaging tool that uses 
photons of two different intensities to measure bone mineral attenuation, allowing for a reliable 
method to measure areal BMD (aBMD), or bone mineral density per unit of surface area 
(mg/cm
2
). DXA measurements represent a three-dimensional (3D) structure as a 2D projection 
and are sensitive to patient positioning and subject size. If the limb of the patient is rotated in any 
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direction, aBMD may be altered within a region of interest (ROI). Also, larger patients will have 
larger bones with a larger projected surface area, thus potentially underestimating aBMD. 
Another limitation of DXA is the inability to separately measure subchondral cortical and 
subchondral trabecular BMD.  
 To date, DXA has not been used to determine aBMD in patellae of individuals with knee 
OA. However, DXA has been used to evaluate links between patellar aBMD and PF pain 
syndrome (pain originating from the posterior surface of the patella) [99], post-injury [100, 101], 
and with chondromalacia patella (softening of the undersurface of the patella) [102]. In each 
case, measurement technique and ROI was similar, including the entire patella in lateral view to 
measure aBMD (Figure 2-9). In all these studies, the affected patella had lower aBMD than the 
contralateral unaffected joint. Patellae in injured knees—through a ruptured anterior cruciate 
ligament (ACL)—had from 9.5% to 25% lower aBMD [100, 101], possibly due to inactivity or 
injury [100]. In patients with PF pain syndrome, affected patellae had 2.5% lower aBMD than 
the healthy contralateral knee [99]; and patients with chondromalacia patella had up to 6.8% 
lower aBMD than in the contralateral knee [102]. These studies used the contralateral knee for 
comparison, allowing for near equal projected surface area between affected joints and 
unaffected joints, nearly eliminating the concern of unequal ROI between groups and patients. A 
summary of these studies is presented in Table 2-4.  
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Figure 2-9. Region of interest (ROI) for studies using DXA to measure aBMD in patellae with 
various afflictions (R3) [100].
 Table 2-4. Summary of related studies using DXA to measure patellar aBMD. 
Author Condition 
# of subjects 
Results 
Findings Comments Control Condition 
Control Comparison Mean SD or range Mean SD or range 
Murphy 
et al.  
2002 
Chondromalacia 
patella 
16* 14 1.051g/cm2 0.896g/cm2 to 
1.266g/cm2 
0.979g/cm2 0.763g/cm2 to 
1.77 g/cm2 
 Lower aBMD in 
patients with 
chondromalacia 
patella (p=0.016) 
 Females only 
 Reduction in 
BMD was limited 
to patella. 
 Chondromalacia 
patella 
11** 11 0.969g/cm2 0.823g/cm2 to 
1.188g/cm2 
0.906g/cm2 0.763g/cm2 to 
1.177g/cm2 
 Lower aBMD on 
more 
symptomatic side 
(p=0.005) 
 Females only 
 Reduction in 
BMD was limited 
to patella. 
Leppala 
et al. 
1998 
PF pain 
syndrome 
40** 40 1.165 g/cm2 0.104 1.31 g/cm2 0.092  Lower aBMD on 
more 
symptomatic side 
(2.5% lower, 
p=0.016) 
 Also found lower 
aBMD in distal 
femur (p=0.002) 
and proximal tibia 
(p=0.008) 
Bayar et 
al. 2008 
After ACL 
rupture 
32** 32 1.195 g/cm2 0.012 1.082 g/cm2 0.025  9.46% change in 
aBMD.  Lower 
on knee with 
injury  (p<0.001) 
 Found lower 
aBMD in distal 
femur and 
proximal tibia 
(p<0.001) 
* Control was a healthy sample matched for age and sex. 
** Control was contralateral knee. 
 
2
4
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 The differences in aBMD measurements using DXA reported in these studies represent 
the entire patella, not localized regions or individual tissues, which may have individual roles in 
relation to pain. Lower aBMD in affected patellae may be a result of trabecular bone changes, 
but this is uncertain as DXA is not able to make a distinction between cortical bone and 
trabecular bone. Lower aBMD could also be due to localized changes, such as only near the 
subchondral surface or only near the anterior surface, but again because of the limitations of 
DXA and selected ROI, we do not know if the observed changes are specific to one region of the 
patella or if it is representative of the entire bone. 
 
2.4.3. Magnetic Resonance Imaging (MRI) 
MRI is the only imaging tool with the capability to observe changes in bone as well as 
surrounding soft tissues, such as cartilage. MRI offers non-ionizing radiation and 3D images. It 
functions by applying a series of magnetic fields to the atomic nuclei in the body, producing a 
rotating magnetic field detected by the scanner. However, MRI has certain limitations. First, 
MRI is poorly suited to measuring bone as bone is primarily composed of calcium 
hydroxyapatite (only having one available proton to generate a magnetic field), which produces 
minimal signal. Bone therefore appears as primarily black space on MRI scans, making analysis 
difficult. Instead, MRI can assess bone properties by indirectly imaging bone through imaging 
surrounding fluid, offering indirect measures of bone as a ratio of bone volume per total volume 
(BV/TV), a similar measure to BMD and a surrogate measure of mechanical properties [7]. This 
makes MRI best suited for assessing subchondral trabecular bone, as opposed to subchondral 
cortical bone, because there is more water-rich fluid surrounding trabecular bone than cortical 
bone.  
 To date, only one study has used MRI to assess OA and normal patellae using cadaveric 
specimens [96]. In these studies, a ROI was limited to a 7mm x 7mm area on each of the lateral 
and medial plateaus within regions of trabecular bone (Figure 2-10), omitting subchondral 
cortical bone was from the ROI, and from the analysis, because it produced a black MR signal. 
This study did not find differences in trabecular BV/TV between normal, moderate OA and 
severe OA patellae (p>0.05) [96]. A summary of these results is presented in Table 2.5.  
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Figure 2-10. ROI in patella using MRI as assessed by Lammentausta et al. [7, 96].  
2.4.4. Computed Tomography (CT) 
Computed tomography is an X-ray technique that collects thin imaged ―slices‖ of the body. 
Multiple images from adjacent slices can be reconstructed to create an imaged 3D volume. In 
quantitative computed tomography (QCT), calibrated reference phantoms are used to convert 
CT-acquired grayscale Hounsfield units (HU) to equivalent volumetric BMD (vBMD, mg/cm
3
). 
These measurements provide an improved BMD measurement over DXA and are less influenced 
by positioning and patient size. Also, QCT is capable of differentiating between cortical and 
trabecular bone [103], allowing for measurements at different regions and layers within the same 
bone.  
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2.4.4.1. QCT and pQCT 
Clinical QCT and peripheral QCT (pQCT) are two CT techniques applied to measure BMD in 
OA and normal joints.  
 
2.4.4.2. pQCT 
pQCT offers small voxel size, allowing for measurement of very small changes in BMD. 
However, pQCT is typically limited in a clinical setting as it is often limited to a single axial 
scan, such as the leg or the arm. Also, gantry sizes are typically small, limiting patellar or distal 
femur imaging in vivo.  
To date, only one study [96] has used pQCT to compare BMD in cadaveric patellae 
without OA, with moderate OA, and with severe OA. This study used the same 7mm x 7mm 
ROI (only measuring subchondral trabecular bone) as the previously discussed MRI study 
(Figure 2-10), with a 0.5mm slice thickness and 0.200mm in-plane resolution (voxels are 
0.200mm x 0.200mm x 0.5mm). Participants showing no signs of OA had significantly higher 
patellar trabecular BMD than those with late OA (p<0.05) [96]. A summary of these results is 
presented in Table 2-5. 
 Table 2-5. Summary of OA-related studies using MRI and pQCT measuring patellar BMD.  
Author 
Imaging 
type 
# of subjects/specimens 
Measurement 
Results 
Findings Comments Control Condition 
Control OA Mean SD Mean SD 
Lammentausta 
et al. 2006
* 
MRI 84 samples 
from 14 
patellae 
 BV/TV 0.459 0.099    Linear 
correlation 
coefficient 
between 
BV/TV and 
vBMD is 
r=0.66 
(p<0.01) 
 
 BMD varies 
with location  
 Higher vBMD 
in superior 
third   
pQCT vBMD  387.6  101.7   
Lammentausta 
et al. 2007 
MRI 6 (normal) 11  
(moderate 
OA) 
 
7  
(advanced 
OA) 
BV/TV 0.45
** 
 0.46
**
 
(moderate 
OA) 
0.44
**
 
(advanced 
OA) 
  Linear 
correlation 
coefficient 
between 
BV/TV and 
vBMD is 
r=0.66 
(p<0.01) 
 Using pQCT, 
advanced OA 
had lower 
BMD than 
normal 
(p<0.05) 
pQCT vBMD  400 
mg/cm
3**
 
 380 mg/cm
3**
 
(moderate 
OA) 
340 mg/cm
3**
 
(advanced 
OA) 
 
* Study to determine relationships between BV/TV and BMD. 
** Value estimated from figure.  
 
2
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 Clinical QCT is more widely used than pQCT and offers many positive attributes for 
measuring BMD. Clinical QCT also offers small isotropic voxels (0.5-0.625mm), reducing 
partial volume artifacts. Scanning time is relatively short (~2.9s for hundreds of scans [23]) 
reducing concern for motion artifacts. Patients are exposed to ionizing radiation during a QCT 
scan, which may cause concern, but the knee has a low presence of radiosensitive tissues. A 
typical lower limb scan has a low effective dosage of ~0.15mSv [23], compared to an average of 
dose of 2.4mSv from annual exposure to background radiation [104] and approximately 0.05mSv 
during a transatlantic flight [105].  
 
2.4.4.3. CT-based image processing 
Image processing tools, such as CT-osteoabsorptiometry (CT-OAM) [33, 106, 107] and CT-
topographic mapping of subchondral density (CT-TOMASD) [23, 24, 26] can be applied to QCT 
scans to measure BMD.  
 
2.4.4.4. CT-OAM 
CT-OAM is a CT-based imaging technique that uses maximum intensity projection image 
processing to select peak density within the subchondral region [106, 107]. Less dense bone 
above and below the peak density is ignored, and maximum density is projected to a 2D image. 
CT-OAM has been used in healthy patellae to measure peak density along the subchondral 
surface [33, 107], as well as density and strength distribution [108]. Surface distribution maps 
show that regions with higher density occur towards the central and superior region of the lateral 
facet (Figure 2-11) [33]. Unfortunately, these studies did not incorporate a calibrated reference 
phantom and cannot be used to reliably assess subchondral BMD in the patella. CT-OAM only 
provides maximum density, primarily at the subchondral cortical depth [24], and does not have 
the capability to perform analyses of less dense bone, such as subchondral trabecular bone.  
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Figure 2-11.  Density distribution of subchondral bone density in the patella (in Hounsfield 
Units (HU)) as demonstrated by CT-OAM.  (Adapted from Eckstein et al. [33]).  
2.4.4.5. CT-TOMASD 
CT-TOMASD is a recently developed depth-specific image processing tool
 
[23]
 
that has been 
used to quantify subchondral BMD in the proximal tibia between healthy individuals and 
individuals with OA [24] (Figure 2-12). This imaging tool measures BMD at progressive depths 
from the subchondral surface (0-2.5mm, 2.5-5mm, and 5-10mm), and is able to differentiate 
between subchondral cortical and subchondral trabecular bone (based on BMD measurements 
[35]). CT-TOMASD is also capable of measuring regional BMD, as demonstrated by 
simultaneously measuring the anterior, central, and posterior regions of the tibial subchondral 
surface [23]. This method also uses isotropic voxel sizes, allowing for reformatting images in 
various orientations (transverse, coronal, or sagittal) without concern of stairstepping artifacts (as 
found when voxel dimensions are dissimilar).  
 CT-TOMASD also has low in vivo regional precision errors (<5%) in normal and OA 
tibiae at subchondral depths of 0-2.5mm, 2.5-5mm, and 5-10mm [26]. Therefore, this technique 
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has the potential to quantify regional changes in tibial subchondral cortical BMD and 
subchondral trabecular BMD.  
 
Figure 2-12.  CT-TOMASD generated density maps of proximal tibial subchondral bone 
showing average BMD at depths of 0-2.5mm, 2.5-5mm and 5-10mm in joints with OA (top row) 
and healthy joints (bottom row) [26].  
 CT-TOMASD is an effective tool to measure regional subchondral cortical and trabecular 
bone in the tibia [23, 26] and shows much promise in measuring regional subchondral cortical 
and trabecular bone on similar low curvature surfaces, such as the patella. Preliminary regional 
CT-TOMASD precision errors in the patella are generally low (CV%RMS of 0.8% to 7.7%) [109], 
showing the potential to quantify subchondral BMD in patients showing various clinical 
outcomes, such as different pain experiences.  
 
2.5. Summary 
1. OA is a debilitating and painful disease affecting a large proportion of the aging 
population. Typically, patients do not realize they are afflicted with OA until they 
experience pain or stiffness and the joint environment may already be biomechanically 
compromised.  
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2. PF OA is largely misunderstood due to gaps in research concerning the PF joint; 
however, the PF compartment is more likely related to pain.  
3. Subchondral bone is largely innervated and may be related to pain progression and 
pathogenesis. BMD is a surrogate measure of mechanical properties in bone, and may be 
related to pain.  
4. Some imaging tools (radiography, DXA, MRI) have certain limitations that prevent 
depth-specific and regional BMD analysis, especially at the patella—which is difficult to 
reliably image in two dimensions. Also, current imaging tools are not capable of 
independently measuring subchondral cortical and subchondral trabecular bone, which 
may have independent roles in OA pain pathogenesis.  
5. CT-TOMASD has the ability to simultaneously measure subchondral cortical and 
trabecular BMD and may be able to measure patellar BMD.   
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CHAPTER  3 
RESEARCH QUESTIONS AND OBJECTIVES 
3.1. Research Questions 
The question that motivates my research is: What role does subchondral bone play in OA-related 
pain? To help answer this broad question, I aimed to answer the following research questions: 
1. Can CT-TOMASD provide precise in vivo measures of subchondral bone density in the 
patella? 
2. Using CT-TOMASD, are there regional or depth-specific differences in patellar 
subchondral BMD between OA patients with differing pain experiences while at rest? 
 
3.2. Research Objectives 
To answer my research questions, my objectives were to: 
1. Determine the in vivo precision of patellar subchondral bone density measures obtained 
using CT-TOMASD.  
2. Identify regional and depth-specific subchondral density differences in patellae of OA 
patients with different pain experiences at rest.  
  
32 
CHAPTER  4 
IN VIVO PRECISION OF CT-TOMASD MEASURES AT THE PATELLA 
4.1. Synopsis 
This chapter describes our testing of the in vivo precision of the CT-TOMASD measures in 
patellae with and without evidence of OA. In vivo precision errors ranged from 1.1% to 6.8%. 
This study provides evidence that the CT-TOMASD technique is suitable for analyses of 
subchondral bone density in the patella.  
 
4.2. Introduction 
The role of subchondral bone in knee OA progression in unclear [1, 3], particularly in the lesser-
explored patella [40]. Currently, the majority of our understanding of subchondral bone changes 
in OA is from animal models or cadaveric studies, as opposed to in vivo imaging studies. 
 Clinically-based CT imaging tools, such as CT-TOMASD [23], have been used to 
precisely measure proximal tibial subchondral cortical and trabecular BMD both ex vivo [23, 24]
 
and in vivo [26]. This technique is able to offer precise measures, with in vivo precision errors 
(CV%RMS) ranging from 0.9% to 3.8% using clinical CT. However, it is uncertain if the 
technique offers precise density measurements of other bony sites, such as the patella. 
 The objective of this study was to test the short-term precision of CT-TOMASD for 
measurements of patellar subchondral cortical and subchondral trabecular BMD in healthy 
individuals and individuals with OA.  
4.3. Methods 
4.3.1. Study Sample 
Fourteen participants (3M:11F) were recruited with ages ranging from 23 to 71 years (mean 
±standard deviation (SD): 49.9 ±11.9 years), including 5 left and 9 right knees. Participants 
were not pre-selected for presence of knee OA, but some participants informed that they were 
afflicted with diagnosed knee OA or undiagnosed knee pain. Left or right knees were randomly 
selected, unless the participant had knee pain, where the more painful knee was studied.  
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 All knee scans were retrospectively evaluated for OA presence using the KL OA severity 
scoring system [58] with axial, sagittal and coronal CT reconstructions.  OA severity was 
classified as follows: 
0 Normal, no osteophytes 
1 Possible osteophyte lipping 
2 Definite osteophytes, possible joint space narrowing 
3 Moderate or multiple osteophytes, definite joint space narrowing, some sclerosis and 
possible bony attrition 
4 Large osteophytes, marked joint space narrowing, severe sclerosis and definite bony 
attrition 
Of the 14 knees, seven exhibited evidence of osteophytes and sclerosis, thus were classified as 
OA (1M, 6F; 52.4 +/- 8.7 years; 1 with KL=1-2; 3 with KL=2; 2 with KL=3; 1 with KL=4). The 
remaining 7 participants showed no evidence of OA and were classified as normal (KL=0; 47.3 
+/- 14.8 years). IBR approval was obtained and all participants provided informed consent prior 
to study involvement.  
 
4.3.2. QCT Acquisition 
Single-energy QCT was performed using a clinical CT scanner (Lightspeed 4-slice, General 
Electric, Milwakee, WI, USA). Participants were positioned supine with the knee of interest 
located in the center of the CT gantry. A solid QCT reference spine phantom (Model 3T; 
Mindways Software Inc, Austin, TX, USA) was located below the knee to transform grayscale 
CT Hounsfield units (HU) to equivalent apparent volumetric BMD (mg/cm
3
 K2HPO4). Scanned 
image volumes included the distal femur, patella, and proximal tibia, but for this analysis the 
volume was cropped to include only images of the patella. CT scanning parameters included: 
120 kVp tube voltage, 150 mA tube current, axial scanning plane, 0.625 mm isotropic voxel size 
(0.625 mm slice thickness, 0.625 x 0.625 mm in-plane pixel size), ~240 slices, ~90 s scan time. 
A standard bone kernel (BONE) was used for edge enhancement and postprocessing. Each 
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participant was scanned three times over two consecutive days, with a maximum of two scans 
per day, with repositioning between each scan.  
 
4.3.3. CT Image Analysis 
4.3.3.1. BMD conversion 
From the CT images, grayscale HU were converted to equivalent volumetric BMD (mg/cm
3
 
K2HPO4) using linear regression equations developed from known reference phantom densities 
(r
2
>0.99) (Matlab 2010b; MathWorks, Natick, MA, USA) (Figure 4-1A). 
 
4.3.3.2. Segmentation 
We segmented a set of 2D serial CT images to create a patellar 3D image volume. Each 
transverse plane image was segmented using a semi-automatic region growing technique with 
commercial software (Analyze10.0; Mayo Foundation, Rochester, MN, USA) (Figure 4-1B).  
 We determined subject-specific segmenting thresholds to define the subchondral bone 
surface by using the half maximum height method (HMH) [110, 111]. This technique uses 
histogram line profiles of a small region of the joint surface to define the optimum threshold 
value for the subchondral surface. The HMH value represents the density of a voxel with 50% 
cortical bone and 50% joint space and acts as a minimum value for voxels containing 
predominantly bone.  
 To perform the segmenting, a 2D seed was placed in the subchondral cortical bone region 
of each image using the HMH threshold value to define the boundaries for the segmented portion 
of the image. A stylus and an interactive touch-screen tablet (Cintiq 21uX, Wacom, Krefeld, 
Germany) were used for manual correction to ensure the entire patella was included within the 
segmented image. All pixels within the selected boundaries were included in the segmentation. 
The 2D segmentations were then combined and used to create a 3D volumetric object map, 
which was applied to the imaged patella to be rendered for boundary point selection.  
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4.3.3.3. Alignment 
In order to minimize artifacts due to partial volume effects, CT-TOMASD surface projection 
analyses require the subchondral surface to be relatively flat and oriented approximately parallel 
with each projected image. We addressed these requirements by realigning and reconstructing 
the imaged patella relative to best-fit planes fit to each medial and lateral facet (Matlab). We 
manually selected boundary points in the axial plane (Figure 4-1C) to define the lateral and 
medial patellar surfaces. Fourteen boundary points were selected for each patella: 
 4 sets of 3 points defining the lateral edge, the transverse ridge, and the medial edge at 
equal increments long the surface of the patella, and 
 2 points defining the most superior and most inferior points along the transverse ridge.  
Patellar surfaces were reoriented relative to the ―best-fit‖ plane passing through the selected 
boundary points (defined using singular valued decomposition) (Figure 4-1D).  
 
4.3.3.4. Surface projection 
CT-TOMASD analysis was performed across three layers (0-2.5mm, 2.5-5mm and 5-7.5mm) 
measured in relation to depth form the subchondral surface (Matlab 2010a) (Figure 4-1E). 
Average density was projected to a 2D image to create a rendered image of 3D subchondral 
BMD. We then fit natural cubic splines (Matlab 2010a) to the previously selected boundary 
points to define the edges of the lateral and medial facets.  
 
4.3.3.5. Normalization 
Because patella size may differ between participants, analysis depth was normalized and 
controlled according to subchondral bone surface area and subject-specific patellar volume [23]. 
This process corrects for potentially shallow measurements in large patellae, and potentially 
excessively deep measurements in small patellae (e.g., a 2.5mm normalized depth may be an 
actual measurement of 2.6mm in large patellae and 2.4mm in smaller patellae). 
  
Figure 4-1. Methodological sequence for CT-TOMASD analyses in the patella consists of converting CT grayscale intensity to BMD 
using a QCT reference phantom (A), followed by semi-automatic patellar segmentation in the transverse plane (B). Peripheral and 
interior boundary points are manually selected (C) to define medial and lateral facets; with the patella reoriented relative to ‗best fit‘ 
planes passing through facet boundary points (D). A surface projection image processing algorithm is performed to map 3D 
subchondral density in relation to depth (measured from the subchondral surface) directly at the patellar surface (E). CT-TOMASD 
output is represented through colormaps at each successive depth (F).  
3
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4.3.3.6. Regional analysis 
A series of regional analyses (Figure 4-2) were performed on each 2D projected image (0–
2.5mm, 2.5–5mm, and 5–7.5mm layers), including: 
1. Lateral and medial BMD 
2. Peripheral and central BMD  
3. Superior, middle, and inferior compartment BMD, assessed by dividing each facet into 
three equally spaced subregions [112]. 
 
Figure 4-2. Regional analysis on lateral and medial patellar facets consists of 
superior/middle/inferior as well as central/peripheral divisions. 
4.3.4. Statistical Analysis 
To assess in vivo precision of CT-TOMASD regional density measures, we scanned 14 
participants, 3 times each; for a total of 42 scans with 28 degrees of freedom (DOF) [113]. We 
also assessed the in vivo precision of CT-TOMASD regional measurements in OA (7 
participants, 21 scans, 14 DOF) and healthy (7 participants, 21 scans, 14 DOF) knees. Precision 
of each regional analysis is reported using both absolute values (root mean square standard 
deviation, SDRMS) and as a percentage (root mean square coefficients of variation, CV%RMS) 
[113]. For comparison with related precision errors, mean BMD values for each regional analysis 
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are also reported. To assess repeatability of CT-TOMASD measures in the patella, we used a 
two-way mixed intraclass correlation coefficient (ICC) model [114], which relates inter-subject 
variance to population variance. Statistical analyses were performed using commercial software 
(SPSS 20.0, SPSS Inc, Chicago, Il, USA).  
 
4.4. Results 
Precision errors associated with CT-TOMASD in the patella were small. CV%RMS for both OA 
and healthy participants ranged from 1.1% to 6.8% (average: 2.9%) (Table 4-1). Repeatability 
was high, with ICC ranging from 0.97 to 1.00. In healthy participants, average CV%RMS 
precision errors ranged from 0.7% to 4.9% (average: 2.5%) (Table 4-2), and from 0.9% to 8.6% 
(average: 3.2%) in participants with OA (Table 4-3). Figure 4-3 shows representative colormaps 
of a healthy patella (top row) and a patella with OA (bottom row) at three measured depths of 0-
2.5mm, 2.5-5mm, and 5-7.5mm. Average precision errors were approximately 4 times smaller 
than BMD %-difference between OA and healthy patellae.  
 Table 4-1. Precision results for CT-TOMASD: average BMD measures (mg/cm
3
 K2HPO4) in healthy and osteoarthritic knees (14 
participants, 3 scans each, 28 degrees of freedom). Precision is reported using root mean square standard deviations (SDRMS), 
coefficients of variation (CV%RMS), and intraclass correlation coefficients (ICC).  CV%RMS also includes range of (minimum to 
maximum) CV%RMS values.  
 
Region 
Depth 
0-2.5mm 
 
2.5-5mm 
 
5-7.5mm 
Mean SDRMS CV%RMS ICC 
 
Mean SDRMS CV%RMS ICC 
 
Mean SDRMS CV%RMS ICC 
Lateral facet Total 592 13.2 1.1 (0.2-2.1) 1.00 
 
376 4.6 1.2 (0.2-2.1) 1.00 
 
354 5.3 1.6 (0.7-2.3) 1.00 
 
Superior 629 17.6 1.4 (0.2-2.6) 1.00 
 
453 6.1 1.5 (0.2-3.7) 1.00 
 
455 12.4 2.6 (0.3-4.3) 0.99 
 
Middle 671 6.85 1.1 (0.1-2.6) 1.00 
 
411 10.6 2.5 (0.0-4.8) 1.00 
 
349 10.8 3.2 (0.5-7.2) 0.99 
 
Inferior 450 23.6 5.7 (0.5-12.8) 0.97 
 
254 8.5 3.8 (0.6-9.0) 0.99 
 
257 7.9 3.1 (0.8-6.7) 0.99 
 
Superior-Peripheral 693 8.1 1.2 (0.3-2.4) 1.00 
 
502 10.2 1.9 (0.5-3.6) 0.99 
 
559 21.1 3.8 (1.2-6.6) 0.97 
 
Middle-Peripheral 687 10.6 1.6 (0.4-4.3) 1.00 
 
401 11.9 3.0 (0.8-4.8) 0.99 
 
420 21.1 5.1 (0.1-10.8) 0.98 
 
Inferior-Peripheral 454 26.6 6.8 (1.2-14.7) 0.97 
 
273 13 5.0 (0.8-12.1) 0.99 
 
354 18.2 5.1 (0.8-7.8) 0.99 
 
Superior-Central 590 10 1.8 (0.3-3.9) 1.00 
 
425 7.4 1.9 (0.6-4.4) 1.00 
 
390 13.1 2.8 (0.6-7.2) 0.99 
 
Middle-Central 654 9.7 1.5 (0.2-4.5) 1.00 
 
421 11.3 2.7 (0.8-5.2) 1.00 
 
274 6.5 2.7 (0.5-6.5) 1.00 
 
Inferior-Central 447 23.8 5.6 (0.7-11.3) 0.97 
 
240 10.2 4.1 (0.6-8.9) 0.99 
 
193 3.5 1.9 (0.2-3.5) 1.00 
                
Medial facet Total 481 7.3 1.6 (0.7-2.7) 1.00 
 
289 4.7 1.6 (0.5-3.4) 1.00 
 
268 5.8 2.3 (0.7-5.5) 0.99 
 
Superior-Central 495 13.8 2.6 (0.3-4.8) 0.99 
 
351 6.5 1.8 (0.9-2.7) 1.00 
 
366 16.5 3.7 (0.3-10.7) 0.98 
 
Middle-Central 568 11.3 2.0 (0.7-4.5) 1.00 
 
331 9.7 2.9 (0.6-5.1) 1.00 
 
250 8.9 3.5 (0.7-6.3) 0.99 
 
Inferior-Central 443 12.5 4.0 (0.6-11.7) 1.00 
 
223 8.2 4.1 (0.6-9.3) 0.98 
 
185 4.3 2.5 (0.5-5.2) 1.00 
 
Peripheral 409 15.4 5.0 (0.8-14.5) 0.99 
 
257 7.2 2.8 (0.9-4.1) 1.00 
 
291 12.8 4.4 (1.0-10.4) 0.99 
3
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 Table 4-2. Precision results for CT-TOMASD: average BMD measures (mg/cm
3
 K2HPO4) in healthy knees (7 participants, 3 scans 
each, 14 degrees of freedom). Precision is reported using root mean square standard deviations (SDRMS), coefficients of variation 
(CV%RMS), and intraclass correlation coefficients (ICC).  CV%RMS also includes range of (minimum to maximum) CV%RMS values.  
 
Region 
Depth 
0-2.5mm 
 
2.5-5mm 
 
5-7.5mm 
Mean SDRMS CV%RMS ICC   Mean SDRMS CV%RMS ICC   Mean SDRMS CV%RMS ICC 
Lateral facet Total 615 4.3 0.7 (0.2-0.9) 1.00 
 
407 4.6 1.1 (0.2-1.8) 1.00 
 
382 5.2 1.4 (0.7-2.1) 0.99 
 
Superior 659 9.3 1.5 (0.2-2.6) 1.00 
 
479 6.7 1.6 (0.2-3.7) 1.00 
 
488 13.1 2.4 (0.3-4.3) 0.99 
 
Middle 703 7.2 1.1 (0.1-2.2) 1.00 
 
452 11.4 2.3 (0.5-4.0) 0.99 
 
377 7.8 2.1 (0.8-3.2) 0.98 
 
Inferior 454 15.6 3.6 (0.5-6.5) 0.97 
 
272 7.8 3.0 (0.6-4.5) 0.97 
 
279 8.3 2.8 (0.9-4.6) 0.99 
 
Superior-Peripheral 712 8 1.2 (0.3-2.3) 1.00 
 
507 7.6 1.4 (0.5-2.2) 1.00 
 
592 15.9 2.7 (1.2-4.1) 0.99 
 
Middle-Peripheral 711 9.71 1.3 (0.4-2.0) 1.00 
 
427 12.2 2.7 (0.8-4.6) 0.99 
 
434 17.1 3.9 (0.6-6.3) 0.94 
 
Inferior-Peripheral 447 18.1 4.4 (1.2-7.3) 0.95 
 
289 13.2 4.1 (1.8-6.4) 0.96 
 
384 19.1 4.9 (0.8-6.2) 0.98 
 
Superior-Central 625 11.3 2.0 (0.3-3.9) 1.00 
 
462 8.6 2.2 (0.7-4.4) 1.00 
 
421 16.6 3.1 (0.6-7.2) 0.99 
 
Middle-Central 693 12.7 1.9 (0.2-4.5) 0.99 
 
480 13.0 2.6 (0.8-4.8) 1.00 
 
315 7.0 2.1 (1.1-3.4) 0.99 
 
Inferior-Central 457 17.5 3.7 (0.7-6.7) 0.98 
 
261 11.9 4.3 (0.6-8.9) 0.95 
 
212 4.1 2.1 (0.2-3.5) 0.99 
 
             
Medial facet Total 509 7.6 1.5 (0.8-2.3) 0.99 
 
325 5.9 1.8 (0.9-3.4) 0.98 
 
299 5.8 1.9 (0.7-3.2) 0.99 
 
Superior-Central 511 17.3 3.1 (1.9-4.8) 0.98 
 
384 7.2 1.8 (0.9-2.7) 0.99 
 
402 21.5 4.5 (0.8-10.7) 0.96 
 
Middle-Central 624 13.6 2.1 (0.7-4.5) 0.98 
 
389 11.3 2.8 (0.6-4.9) 0.99 
 
287 10.1 3.2 (1.3-6.3) 0.97 
 
Inferior-Central 454 12.5 2.7 (0.6-4.1) 0.99 
 
247 8.9 3.7 (1.7-7.6) 0.99 
 
201 4.5 2.4 (0.5-5.2) 0.96 
 
Peripheral 441 12.9 2.8 (0.9-5.0) 0.95 
 
287 8.1 2.8 (2.4-3.2) 0.98 
 
331 12.1 3.3 (1.0-7.4) 0.99 
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 Table 4-3. Precision results for CT-TOMASD: average BMD measures (mg/cm
3
 K2HPO4) in osteoarthritic knees (7 participants, 3 
scans each, 14 degrees of freedom). Precision is reported using root mean square standard deviations (SDRMS), coefficients of variation 
(CV%RMS), and intraclass correlation coefficients (ICC).  CV%RMS also includes range of (minimum to maximum) CV%RMS values.  
 
Region 
Depth 
0-2.5mm 
 
2.5-5mm 
 
5-7.5mm 
Mean SDRMS CV%RMS ICC   Mean SDRMS CV%RMS ICC   Mean SDRMS CV%RMS ICC 
Lateral facet Total 569 7.5 1.3 (0.5-2.1) 1.00 
 
345 4.5 1.4 (0.5-2.1) 1.00 
 
326 5.4 1.7 (1.0-2.3) 1.00 
 
Superior 599 6.8 1.2 (0.3-1.6) 1.00 
 
427 5.5 1.3 (0.5-2.2) 1.00 
 
421 11.7 2.8 (1.3-4.0) 0.99 
 
Middle 640 6.5 1.2 (0.3-2.6) 1.00 
 
369 9.6 2.8 (0.0-4.8) 1.00 
 
322 13.1 4.0 (0.5-7.2) 0.99 
 
Inferior 446 29.6 7.3 (0.5-12.8) 0.98 
 
235 9.1 4.5 (1.5-9.1) 0.99 
 
236 7.5 3.3 (0.8-6.7) 0.99 
 
Superior-Peripheral 675 8.2 1.2 (0.7-2.4) 1.00 
 
497 12.2 2.3 (0.5-3.6) 0.99 
 
525 25.3 4.7 (2.1-6.6) 0.95 
 
Middle-Peripheral 663 11.5 1.9 (0.5-4.3) 1.00 
 
376 11.5 3.3 (1.1-4.8) 0.99 
 
406 24.4 6.0 (0.1-10.8) 0.99 
 
Inferior-Peripheral 460 32.9 8.6 (1.6-14.7) 0.98 
 
257 12.7 5.7 (0.8-12.1) 0.99 
 
324 17.3 5.2 (1.4-7.8) 0.99 
 
Superior-Central 555 8.5 1.6 (1.0-2.5) 1.00 
 
387 6.0 1.5 (0.8-2.4) 1.00 
 
359 8.1 2.5 (1.3-3.9) 1.00 
 
Middle-Central 616 5.3 0.9 (0.5-1.4) 1.00 
 
361 9.2 2.8 (0.8-5.2) 1.00 
 
234 6.1 3.2 (0.5-6.5) 1.00 
 
Inferior-Central 436 28.8 6.9 (4.9-11.4) 0.97 
 
219 8.2 3.9 (2.4-5.8) 0.99 
 
175 2.9 1.7 (1.0-2.6) 1.00 
                
Medial facet Total 452 7.1 1.8 (0.7-2.7) 1.00 
 
253 3.0 1.2 (0.5-1.7) 1.00 
 
238 5.8 2.6 (0.9-5.5) 1.00 
 
Superior-Central 479 9 1.9 (0.3-2.5) 1.00 
 
319 5.7 1.8 (0.9-2.7) 1.00 
 
330 9.2 2.8 (0.3-4.3) 1.00 
 
Middle-Central 513 8.5 1.8 (1.2-2.5) 1.00 
 
272 7.7 3.0 (1.1-5.1) 1.00 
 
213 7.6 3.8 (0.7-5.3) 0.99 
 
Inferior-Central 433 12.5 5.0 (0.7-11.7) 1.00 
 
199 7.4 4.6 (0.6-9.3) 1.00 
 
169 4.0 2.7 (0.3-4.3) 1.00 
 
Peripheral 378 17.6 6.6 (1.3-14.5) 1.00 
 
227 6.3 2.8 (0.9-4.1) 1.00 
 
250 13.5 5.3 (1.4-10.4) 0.98 
4
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Figure 4-3. Representative topographical color maps of patellar BMD at depths of 0-2.5mm, 2.5-5mm and 5-7.5mm in healthy 
participants (top row) and participants with OA (bottom row).
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4.5. Discussion 
We studied the in vivo precision of CT-TOMASD measures of patellar subchondral BMD in 
knees of healthy individuals and those with OA. This is the first study to report the precision of 
CT-based BMD values in the patella. This is also the first study to offer in vivo measures of 
subchondral cortical and subchondral trabecular BMD in healthy and OA patellae using clinical 
QCT.  
 Our CT-TOMASD measurements show precise (average CV%RMS less than 5%) in vivo 
measurements of subchondral cortical and subchondral trabecular BMD measured relative to the 
subchondral surface. These in vivo precision errors are within the same range as our preliminary 
precision results [109] and therefore can be considered trustworthy. Low precision error values 
are due to the use of small (0.625mm) isotropic voxels and the ability to reliably reconstruct and 
rotate the 3D image volume in various orientations without compromising resolution in any 
plane. This characteristic, combined with boundary point selection defining each lateral and 
medial facet and short scanning time (~90s), allows for the ability to reconstruct the imaged 
patella in repeatable orientations minimizing the effect of patient positioning.  
 This study has many strengths: an appropriate number of subjects and scans to establish 
conservative precision errors, the inclusion of both healthy participants, and a sample with OA, 
and a comprehensive reporting of precision measures including CV%RMS and ICC. First, we met 
conservative recommendations for number of subjects and scans [113], i.e., 28 degrees of 
freedom with 3 repeated measures on 14 subjects. These recommendations are sufficient to 
establish reliable precision errors will small confidence intervals (30% higher than mean 
precision errors) [113]. Second, our study uses images from both healthy and OA knees for 
precision analysis, offering confident application of the image processing technique to either 
healthy or OA knees in future studies. The inclusion of both groups in our precision analysis 
provides representative precision errors for either healthy or OA knees. If precision analysis is 
limited to only healthy or only OA joints, then results may offer misrepresentative precision 
errors for comparison between normal and OA subchondral BMD in future studies. Third, we 
present a comprehensive analysis by including both CV%RMS and ICC as measures of the 
reliability of CT-TOMASD in the patella, allowing us to evaluate the reliability of individual 
density measures. The CV%RMS measures provide an assessment of the variation in density 
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measures between multiple scans while the ICC provides a measure of homogeneity, or 
consistency, of repeated BMD measurements.  
 Limitations of this study relate to our sample size and OA classification. Although we 
have met recommendations for conservative determination of precision errors [113] in our 
overall sample (14 participants, 42 scans, 28 DOF), our mixed sample has participants with OA 
(7 individuals, 21 scans, 14 DOF) and healthy participants (7 individuals, 21 scans, 14DOF). Our 
reported CV%RMS and ICC values represent conservative assessments of CT-TOMASD 
precision in a range of participants with and without OA. This was deliberate as we wanted to 
increase the variability of BMD measures in our precision measurement for use of CT-TOMASD 
in future studies comparing participants with and without OA. Independently determining 
precision errors for samples with and without OA would require twice as many participants (14 
with OA and 14 without OA) and would inflict unnecessary radiation to more participants. Our 
separate analysis of participants with OA and participants without OA yielded similar precision 
errors as the combined sample, so our decision to combine groups to meet conservative 
recommendations [113] is justified. Secondly, our OA classification was performed 
retrospectively through CT volume reconstruction as opposed to being based on a clinical 
diagnosis. Clinical OA classification is performed by assigning KL grade qualifiers [58] to 
individual joints and requires a series of radiographs in various orientations; and would increase 
effective radiation dosage in participating volunteers.  
 There are also certain limitations with the CT-TOMASD image processing tool that need 
to be considered. The 2D projection nature of CT-TOMASD could induce over- or under-
estimation of density at the subchondral bone surface in regions with excessive curvature [23], 
particularly around the patellar periphery. To reduce these effects, we used best-fit planes and 
reorientations, then reconstructed each volume to find the position with the lowest curvature on 
each facet. Also, we used an image-specific HMH threshold [110] to locate the subchondral 
surface of each unique patellar volume, as well layer analyses averaging density over different 
depths of 2.5mm from the surface. The combination of techniques minimizes the effect of partial 
volume artifacts at the subchondral surface. Another limitation of the CT-TOMASD technique is 
the amount of manual, and possibly subjective, intervention. Even though patient-specific 
boundary points are selected while referring to all three orientations (transverse, coronal, and 
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sagittal) to ensure correct placement, they are manually selected possibly increasing user-induced 
error.  
 On the anterior patellar surface, our precision errors were largest in peripheral regions 
where the effect of partial volume artifacts could be high. However, the precision errors of 
superior/middle/inferior regions are generally low (<5%), with peripheral regions having little 
effect on total region precision. For these reasons, we believe that the effects of the anterior 
patellar surface on CT-TOMASD measures are small. Second, as with any QCT-based imaging 
technique, participants are exposed to ionizing radiation.  As the knee has a low presence of 
radiosensitive tissues, QCT analyses at this location result in a low effective dosage 
(~0.073mSv) [23].  
 
4.6. Conclusion 
Regional patellar in vivo CT-TOMASD precision errors ranged from 1.1% to 6.8% at depths of 
0-2.5mm, 1.2% to 5.0% at depths of 2.5-5mm and 1.6% to 5.1% at depths of 5-7.5mm in a 
sample of healthy and OA participants. These results suggest that this technique has the potential 
to identify and quantify OA-associated subchondral BMD changes in the patella, in vivo.  
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CHAPTER  5 
CT-TOMASD IN PATIENTS WITH CLINICALLY DIAGNOSED OA 
5.1. Synopsis 
This chapter describes our study using CT-TOMASD to measure BMD at three successive 
depths (0-2.5mm, 2.5-5mm and 5-7.5mm) in a group of participants with clinically diagnosed 
OA. The participants were divided into two groups—those experiencing ‗severe pain at rest‘ and 
those experiencing ‗non-severe pain at rest‘. Participants experiencing ‗severe pain at rest‘ had 
lower BMD at depths consisting primarily of trabecular bone than participants experiencing 
‗non-severe pain at rest‘.  
 
5.2. Introduction  
Although generally considered a disease related to cartilage, OA is marked by changes to many 
joint tissues [9, 54, 115], including the underlying subchondral bone [116]. Cartilage is aneural 
and insensate [22], but underlying subchondral bone is innervated [19, 117] and could be a factor 
in OA-related pain. Trabecular bone has a greater concentration of nerve endings than cortical 
bone [75] and could be an initiation site for pain.  
 OA-related pain at rest (e.g., sitting, lying down, nocturnal pain) is of great concern to 
patients because it is related to sleeplessness and other disruptions in quality of life [62]. 
Although pain is related to clinical radiological measures of PF OA disease severity (e.g., 
sclerosis, osteophyte presence) [12, 66, 67], the strongest relationships are present in cases with 
severe OA [11]. This could be due to the inherent limitations of 2D imaging modalities, 
including limited radiographic skyline views of the patella and projection images (which may 
superimpose radiographic features of OA). Currently available 3D imaging modalities, such as 
QCT, allow the patella to be viewed from all angles and can also be used to assess 3D 
subchondral BMD [103]. CT-TOMASD has the potential to determine BMD measurements at 
progressive depths that approximate distinctions between subchondral cortical BMD and 
trabecular BMD layers [23], which may have different roles linked to OA-related pain.  
 The objective of this study was to determine whether there are measurable differences in 
patellar subchondral BMD between OA patients with different pain experiences, particularly 
pain at rest. 
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5.3. Methods 
5.3.1. Study Sample 
Fifty-two participants (23M:29F; mean age 64, SD±9years) were recruited for this study prior to 
total knee replacement. Study exclusion criteria included pregnant women, participants having a 
revision knee replacement instead of primary knee replacement, prior history of bone pathology 
at the knee joint, and those who were not able to complete the OA severity index tests. We 
excluded any images with excessive imaging artifacts, motion artifacts or incomplete images, 
leaving 42 participants (17M:25F; mean age 64, SD±10years).  
 
5.3.2. Clinical Assessment 
Each participant was assessed for pain at the affected knee joint using a 5-point Likert scale of 
the pain subsection of the Western Ontario McMasters Osteoarthritis Index (WOMAC) [8, 118], 
which evaluates 5 pain items, 17 function items and 2 stiffness items. Participants were asked to 
assess the level of pain in the affected knee joint within the past 24-hours while walking on a flat 
surface, going up or down stairs, lying in bed, sitting or standing upright.  
We defined ‗at rest‘ by dividing the WOMAC pain subsections into rest activities (lying 
in bed, sitting down) and weight-bearing activities (walking, up/down stairs) [64, 78] and 
considered any participants who scored a 3 (severe pain) or 4 (extreme pain) in either rest 
activity (while lying down or sitting) as having ‗severe pain at rest‘. Those not scoring a 3 or 4 in 
either rest activity were considered to have  ‗non-severe pain at rest‘ [119]. No patients scored 0 
(no pain) in both rest activities. The sample was divided with 21 participants in the ‗severe pain 
at rest‘ grouping and 21 participants in the ‗non-severe pain at rest‘ grouping (Table 5-1). All 
patients had radiographic OA severity of KL grade 3 or 4.  
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Table 5-1. Background characteristics and clinical data for ‗non-severe pain at rest‘ and ‗severe 
pain at rest‘ groups. There were no differences between groups in age and BMI (assessed using t-
tests) or sex (assessed using χ2 test).  
 
Non-severe Pain at Rest 
(N=21) 
Severe Pain at Rest 
(N=21) 
WOMAC 0, 1 or 2 3 or 4 
Sex Ratio 9M:12F 8M:13F 
Age in years (mean ± SD) 65.0 ± 10.4 63.2 ± 9.93 
BMI in kg/m
2
 (mean ± SD) 29.1 ± 3.05 28.2 ± 4.23 
KL Grade 3 to 4 3 to 4 
 
5.3.3. CT Acquisition 
We collected CT data using single-energy quantitative CT (QCT) via a clinical CT scanner 
(Lightspeed 4-slice, General Electric, Milwaukee, WI, USA). Participants were oriented supine 
within the CT gantry, with both legs scanned simultaneously. Below the patients‘ legs, we 
included a solid QCT reference phantom (Model 3T, Mindways Software Inc, Austin, TX, USA) 
to convert grayscale CT Hounsfield Units (HU) to equivalent apparent BMD (mg/cm
3
 K2HPO4). 
Scans of both knees included the distal femur, the proximal tibia and the patella; though only the 
patella was used in this analysis. CT scanning parameters included: 120kVp tube voltage, 
150mA tube current, axial scanning plane, 0.625mm isotropic voxel size (0.625mm slice 
thickness, 0.625 x 0.625mm in-plane pixel size), ~254 slices, ~60s scan time and 0.073mSv 
radiation dosage. A standard bone kernel (BONE) was used for CT image post-processing.  
 
5.3.4. CT Image Analysis 
The imaging methodology used has been previously described in detail (Chapter 4). We followed 
the same process for BMD conversion, segmentation, alignment, surface projection, and 
normalization. The regional analysis was modified as we only focused on the superior, middle, 
and inferior regions of the lateral facet.  
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5.3.5. Regional analysis 
We performed a regional analysis of the lateral facet on each 2D projection image (0-2.5mm, 
2.5-5mm and 5-7.5mm layers); dividing the surface of the lateral facet into three equally spaced 
sections relative to superior-inferior height (Figure 5-1). We report average BMD on the 
following surfaces: total lateral facet, superior lateral facet, middle lateral facet, and inferior 
lateral facet; as the lateral facet has up to 60% more load applied than the medial facet [30]. We 
defined depths between 0-2.5mm as the patellar subchondral cortical region based on reported 
cortical thickness of 0.1-2.1mm [120] and depths beneath 2.5mm as trabecular bone regions 
based on average BMD below 400mg/cm
3
 [35].  
 
Figure 5-1.  Position of superior, middle and inferior regions on lateral patellar facet.   
5.3.6. Statistical Analysis  
We first tested the equality of variances in subchondral BMD outcomes using Levene‘s test and 
between group differences in potential confounding factors for BMD with χ2 test (sex) and t-tests 
(age, body mass index (BMI)). There were no differences in BMD variances or sex distribution, 
age, and BMI between the ‗severe pain at rest‘ and ‗non-severe pain at rest‘ groups (Table 5-1), 
therefore we used independent t-tests to compare between group differences in mean 
subchondral patellar BMD across regions. We report mean and standard deviation (SD) for 
lateral surface BMD outcomes for both groups, as well as mean %-differences with 95% 
confidence intervals for pair-wise comparisons between ‗severe pain at rest‘ and ‗non-severe 
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pain at rest‘ groups. We considered an α-level less than 5% statistically significant. Statistical 
analyses were performed using commercial software (SPSS 19, SPSS Inc, Chicago, IL, USA).  
 
5.4. Results 
Across the total lateral facet, there was a trend towards lower total BMD at each successive 
depth in participants experiencing ‗severe pain at rest‘ compared to those with ‗non-severe pain 
at rest‘ (Figure 5-2). Mean BMD was 16.7% lower at the 5-7.5mm depth in the total lateral facet 
in patients with ‗severe pain at rest‘ (mean difference: - 53mg/cm3; 95% CI: -103 to -3mg/cm3; 
p=0.04) (Table 5-2, Figure 5-2, Figure 5-3, Figure 5-4).  
Regionally, mean BMD was 16.4% lower at the 5-7.5mm depth in the superior lateral 
facet in patients with ‗severe pain at rest‘ (mean difference: -67mg/cm3; 95% CI: -131 to -
4mg/cm
3
; p=0.04) (Table 5-2, Figure 5-2, Figure 5-3, Figure 5-4). BMD was also lower in the 
lateral inferior region in the ‗severe pain at rest‘ group at each depth from the subchondral bone 
surface (Figure 5-2). BMD at the inferior lateral facet was 13.1% lower at the 0-2.5mm depth 
(mean difference: -66mg/cm
3
; 95% CI: -125 to -7mg/cm
3
; p=0.03), 23.0% lower at the 2.5-5mm 
depth (mean difference: -62mg/cm
3
; 95% CI: -104 to -20mg/cm
3
; p=0.005), and 21.8% lower at 
the 5-7.5mm depth (mean difference: -52mg/cm
3
; 95% CI: -95 to -9mg/cm
3
; p=0.02) (Table 5-2, 
Figure 5-2, Figure 5-3, Figure 5-4). There were no observed differences at other regions or 
depths.  
  
 
Figure 5-2. Representative topographical color maps of average lateral patellar BMD at depths of 0-2.5mm, 2.5-5mm and 5-7.5mm in 
participants reporting ‗severe pain at rest‘ (top row) and ‗non-severe pain at rest‘ (bottom row). 
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 Table 5-2. Mean ± standard deviation (SD), absolute mean difference, percent difference, 95% confidence intervals (CI) and p-value 
of bone mineral density (BMD) measurements in patients with knee osteoarthritis with ‗severe pain at rest‘ and ‗non-severe pain at 
rest‘. 
Region Depth 
BMD (mg/cm3 K2HPO4) 
Mean difference (%) 
95% Confidence Interval 
(mg/cm3 K2HPO4) P-value  Severe Pain Non-severe Pain 
Mean ± SD Mean ± SD Lower Limit Upper Limit 
Lateral Facet        
Total 0-2.5 mm 522 ± 82 557 ± 94 -35 (-6.3%) -90 20 0.21 
 2.5-5 mm 298 ± 87 347 ± 82 -49 (-14.1%) -101 4 0.07 
 5-7.5 mm 263 ± 77 316 ± 84 -53 (16.7%) -103 -3 0.04 
Superior 0-2.5 mm 554 ± 88 573 ± 104 -19 (-3.3%) -80 40 0.51 
 2.5-5 mm 353 ± 95 405 ± 106 -52 (-12.8%) -115 11 0.10 
 5-7.5 mm 341 ± 94 408 ± 110 -67 (-16.4%) -131 -4 0.04 
Middle 0-2.5 mm 559 ± 93 586 ± 104 -27 (-4.6%) -88 35 0.39 
 2.5-5 mm 323 ± 104 366 ± 98 -43 (-11.7%) -106 20 0.17 
 5-7.5 mm 262 ± 90 312 ± 97 -50 (-16.0%) -109 7 0.09 
Inferior 0-2.5 mm 438 ± 94 504 ± 94 -66 (-13.1%) -125 -7 0.03 
 2.5-5 mm 208 ± 75 270 ± 59 -62 (-23.0%) -104 -20 0.005 
 5-7.5 mm 187 ± 71 239 ± 66 -52 (-21.8%) -95 -9 0.02 
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Figure 5-3. 95% confidence intervals (CI) of mean difference in BMD between ‗severe pain at rest‘ and ‗non-severe pain at rest‘ 
groups in the total lateral facet (top 3 intervals) and inferior lateral facet (bottom 3 intervals) at depths of 0-2.5mm, 2.5-5mm and 5-
7.5mm.
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Figure 5-4. Percentage difference in total lateral BMD (left) and inferior lateral BMD (right) between patients showing ‗severe pain at 
rest‘ and ‗non-severe pain at rest‘. Error bars represent percentage standard error of difference.  
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5.5. Discussion 
The CT-TOMASD method detected lower patella BMD across various depths and regions in OA 
patients with ‗severe pain at rest‘ when compared to OA patients with ‗non-severe pain at rest‘. 
This is the first study to assess depth-specific bone density in the patellar subchondral region. 
This is also the first study to link local patellar bone density with pain. These findings suggest 
that there may be previously unobserved changes in patellar subchondral bone density relating to 
OA, particularly in patients experiencing ‗severe pain at rest‘.  
 The CT-TOMASD image processing technique demonstrated lower patellar BMD in the 
‗severe pain at rest‘ group when compared alongside the ‗non-severe pain at rest‘ group, with 
large differences observed at depths of 2.5-5mm (p=0.005) and 5-7.5mm (p=0.02) (which consist 
primarily of trabecular bone). Our results suggest that low subchondral trabecular bone density 
may have a role in OA-related pain pathogenesis.  
Our findings are consistent with prior research reporting OA-related alterations in 
subchondral trabecular bone. A pQCT study of the patella [96] has reported decreased trabecular 
BMD with progressing OA severity. Canine studies have reported lower trabecular BMD in 
posttraumatic OA-affected joints than in healthy joints [121, 122]. Our results suggest that 
subchondral trabecular bone may be a key area of interest in the OA knee.  
Our study has revealed a potential area where current tools and OA-assessment 
techniques may be limiting. Reported correlations between radiographic measures of OA (e.g. 
osteophyte presence, sclerosis) and pain are poor but significant in cases where pain is severe-to-
extreme (WOMAC) and OA severity is high (KL) [11, 53, 123]. The KL scale [58] combines 
osteophyte presence, joint space narrowing and sclerosis (which is essentially high BMD) to 
determine disease severity in standardized skyline [74] views to assess OA severity in the 
patella. Although the KL technique may be sufficient in a clinical setting, poor relationships 
between disease severity and pain could be due to two separate complications. First, disease 
severity is partly based on the measurement of sclerosis. In this study, we found that lower 
localized BMD—as opposed to sclerotic bone with high BMD—is significantly related to pain, 
providing evidence for a new potential area of interest in the investigation of the role of bone in 
OA. Second, the use of 2D radiographs does not allow the patella to be viewed from all angles, 
potentially allowing other features in other regions not seen in skyline view, like the inferior 
lateral facet, to be overlooked. This emphasizes the need to use other imaging modalities such as 
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3D QCT and image processing tools such as CT-TOMASD when assessing the relationship 
between pain and subchondral bone changes. 
This study has specific strengths. First, this was a homogeneous sample of OA patients 
scheduled for knee arthroplasty with similar distribution of possible confounding factors (age, 
sex, BMI) for BMD in both ‗severe pain at rest‘ and ‗non-severe pain at rest‘ groups. We were 
therefore able to focus our analysis on comparing BMD measurements without adjusting for 
possible confounding factors. Second, using 3D QCT and CT-TOMASD we measured the 
density of thin subchondral bone layers near the patellar subchondral bone surface. Such 
measures would be fundamentally unreliable had they been acquired using 2D imaging tools 
such as clinical radiography or dual energy x-ray absorptiometry (DXA). Other 3D imaging tools 
are unable to perform density measurements of subchondral bone layers near the articulating 
surface. Third, we aligned all patellae in similar 3D orientations relative to landmark boundary 
points and best-fit planes. This minimized BMD differences due to dissimilar orientations, 
thereby permitting reliable comparisons between groups.  
This study has certain limitations that require consideration regarding pain location and 
participant physical activity. First, clinical pain assessment for the participants was based upon 
the entire knee, including the patella, proximal tibia, distal femur, tibiofemoral joint and 
patellofemoral joint. For this reason, we are uncertain if pain at rest originated from the patella, 
other tissue, or a combination of tissues. Second, patient physical activity level was unknown—
which could affect BMD measurements[124]—and we are uncertain if the observed lower BMD 
in the ‗severe pain-at-rest‘ group was a result of inactivity, as a result of pain. To address this 
concern we estimated bone strength by measuring and comparing cortical cross-sectional area at 
the 66% site proximal to the distal tibial end-plate[125] using independent t-tests (data not 
shown); and found no difference between ‗severe pain at rest‘ and ‗non-severe pain at rest‘ 
groups (p=0.61), implying that both groups had similar levels of bone strength, thus similar 
physical activity levels [126]. 
 Although speculative, it is worthwhile hypothesizing why a loss of trabecular bone may 
be related to pain at rest. Our preliminary finite element (FE) analyses of articulating bones, 
though limited to the proximal tibia [127], have shown that trabecular bone (as opposed to 
commonly assumed subchondral cortical bone) has the most dominant effect on overall structural 
stiffness at bony ends. Using these FE findings as a guide, a loss of trabecular bone in the patella 
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will lead to a more flexible structure. Pain may then arise from increased strain or deformation 
(due to increased flexibility) of remaining trabeculae supporting overlying subchondral cortical 
bone and cartilage. Increased trabecular strain may also increase strain in subchondral cortical 
bone (due to increased bending) leading to pain. Various researchers have also theorized links 
between pain and intraosseous pressure [6, 83]. In line with this theory, local trabecular bone loss 
may alter intraosseous pressure distributions, leading to increased local pressure and pain. 
Further research is needed investigating potential links between bone mechanics and pain.  
 
5.6. Conclusion 
This study found that total and superior lateral facet BMD was lower in patients experiencing 
‗severe pain at rest‘ than patients with ‗non-severe pain at rest‘ across the 5-7.5mm depth. BMD 
at the inferior lateral facet was lower in participants with ‗severe pain at rest‘ at each depth, 
particularly in regions comprised of trabecular bone. This study suggests that subchondral 
trabecular bone may be involved in OA-related pain. 
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CHAPTER  6  
INTEGRATED DISCUSSION 
6.1. Overview of findings 
CT-TOMASD is a QCT-based imaging program able to perform regional analyses near the 
articulating surface of the patella in both cortical (0-2.5mm) and trabecular (2.5-5mm and 5-
7.5mm) bone layers. It overcomes various limitations of other bone imaging modalities, e.g., 
radiographs and DXA are limited to 2D imaging and are unable to distinguish between trabecular 
and cortical bone; MRI does not depict bone mineralization is best suited for measuring 
trabecular bone, rather than cortical bone; and pQCT is limited to a single axial image. CT-
TOMASD is capable of overcoming all these limitations by using a 3D imaged volume to 
measure regional BMD at various depths from the subchondral surface. As demonstrated in this 
study, CT-TOMASD could be used to precisely measure in vivo patellar subchondral BMD in 
patients with clinically diagnosed OA, which could help clarify the role of subchondral bone 
changes in OA progression and potentially providing vital information in improving OA 
diagnosis and treatment.  
 A key accomplishment of Chapter 4 – In vivo Precision of CT-TOMASD Measures at 
the Patella is that we demonstrated CT-TOMASD could be used to measure, in vivo, patellar 
subchondral BMD in OA and normal knees with precision errors many times smaller than 
differences between OA and normal density (~4x smaller on average). We found that CT-
TOMASD was capable of precisely imaging distinct subchondral bone layers with low precision 
errors (mean CV%RMS <5%). The in vivo precision errors reported in this study represent a 
worst-case scenario, as they include the possibility of patient positioning and movement errors 
with a widely available commercial CT system in a routine environment. This is important 
because we can now confidently use CT-TOMASD to assess BMD differences between OA and 
healthy patellae from a clinical setting. Our results show that CT-TOMASD is a versatile 
technique that can be confidently applied to the articulating patellar surface, as well as the 
previously explored tibia [23, 24, 26].  
 The first key accomplishment of Chapter 5 –CT-TOMASD in Patients with Clinically 
Diagnosed OA is that we presented, for the first time, 3D patellar subchondral cortical and 
trabecular BMD values from a clinical sample of OA patients experiencing knee pain. As a 
second key accomplishment, we found that patients with ‗severe pain at rest‘ had lower BMD in 
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the inferior regions of the patella than individuals with ‗non-severe pain at rest‘, particularly at 
depths where trabecular bone was prominent (2.5-5mm and 5-7.5mm). This study shows that 
subchondral cortical and subchondral trabecular bone may play different roles in OA-related 
pain, and trabecular bone may be a key site of interest in relation to pain pathogenesis.  
 
6.2. Comparison to Existing Findings 
Our in vivo precision of CT-TOMASD in the patella is similar to previously reported in vivo 
precision in the tibia [26], as well as a pilot precision study in the patella [109]. CT-TOMASD 
precision errors (CV%RMS) in the patella range from 1.1% to 6.8% in the 0-2.5mm layer, from 
1.2% to 5.0% in the 2.5-5mm layer, and from 1.6% to 5.1% in the 5-7.5mm layer. CT-TOMASD 
precision errors (CV%RMS) in the tibia ranged from 0.9% to 3.9% in the 0-2.5mm layer, from 
1.6% to 4.0% in the 2.5-5mm layer, and from 1.5% to 3.0% in the 5-10mm layer [26]. Our ICCs 
for CT-TOMASD measures in the patella ranged from 0.95 to 1.00, similar to previously 
reported ICC values in the tibia [23]. Previous studies using DXA to measure patellar aBMD 
showed similar CV%RMS of 1.0%, with an ICC of 0.995 [100], showing that CT-TOMASD in the 
patella is just as precise as the current standard BMD measurement tool.  
 Comparisons between CT-TOMASD BMD measures in the patella and existing findings 
are difficult given that this study presents the only reported subchondral cortical BMD measures 
in normal and OA patellae. Our BMD values of patellar subchondral trabecular BMD (at depths 
of 2.5-5mm and 5-7.5mm) are comparable with existing pQCT measures in patients with and 
without OA [96] (Table 2-5). Reported values of 410 mg/cm
3
 in healthy individuals and 
340mg/cm
3
 in individuals with advanced OA [96] are similar to our measurements at depths of 
2.5-5mm (mean BMD of 378 mg/cm
3
 in healthy individuals, mean BMD of 316 mg/cm
3
 in 
individuals with OA) and 5-7.5mm (mean BMD of 360 mg/cm
3
 in healthy individuals, mean 
BMD of 301 mg/cm
3
 in individuals with OA); showing that our results are similar to other 
patellar BMD measurements.  
 In the case of a comparison to symptomatic measures, this is the first study to compare 
BMD and OA-related pain using WOMAC. DXA studies exploring the relationship between PF 
pain and aBMD report lower aBMD in the affected knee [99, 100, 102] as well as increased bone 
turnover in patellae affected with PF pain syndrome [69]. The fundamental limitation of DXA is 
that the ROI includes the entire patella; it is not possible to isolate specific regions or tissues 
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within the DXA projection image. Our results also parallel previous studies examining patellar 
BMD and pain [99, 100, 102], but we were able to isolate the region (inferior lateral facet) and 
bone tissue layer (trabecular bone) associated with lower BMD using CT-TOMASD. This study 
identified that trabecular bone may specifically connected to pain.  
 
6.3. Study Strengths 
This thesis research has various strengths related to the CT-TOMASD technique and clinical 
applications of CT, which require further explanation or have not yet been discussed.  
 CT-TOMASD uses various techniques that allow for analysis of reasonably flat 
articulating surfaces, such as the patella. First, our clinical CT images were collected using very 
small isotropic voxels (0.625mm x 0.625mm x 0.625mm). This allows multi-planar data 
reformations in multiple orientations. This is important, as previously discussed in the tibia [23, 
26], but it even more so in the patella, as it appears as a free-floating bone within the complete 
CT image stack. Using isotropic voxels and 3D image reconstruction allows the entire patellar 
volume to be isolated for analysis independent of joint positioning or alignment. Patellar 
alignment can differ between patients, possibly complicating positioning for typical 2D 
projection analysis through DXA. Small voxel size allows measuring and monitoring small 
changes, and is especially important in the patella because it‘s a relatively small bone compared 
to the other bones in the knee joint. Small voxel size also permits measurement of thin layers, 
again especially important in the patella because the subchondral cortical layer may range from 
0.1mm to 2.09mm [120].  
 This research presents the possibility of assessing BMD as a clinical measure of OA. Our 
results show that clinical CT has capabilities to show previously unmonitored differences in 
trabecular BMD between patients with differing pain experiences. Interestingly, we found lower 
BMD—a characteristic currently overlooked when determining OA severity. Radiographs 
subjectively measure sclerosis, or regionally high BMD, which may measure the wrong 
phenomenon; potentially having overlooking certain cases of OA. This phenomenon may also 
partially explain why some patients are reporting joint pain, without showing radiographic 
evidence of OA. Loss of bone density, as opposed to increased bone density, may thus play a 
role in OA initiation and pain pathogenesis. 
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6.4. Study Limitations 
This thesis research has various limitations related to the study design, study sample size, and 
associated limitations of CT-TOMASD.   
 First, our study design lacked a control sample of healthy subjects representing normal 
patellar BMD values. Our ‗severe pain at rest‘ and ‗non-severe pain at rest‘ groups were 
naturally formed groups within out subject sample representing a convenient subject variable as 
opposed to a more powerful independent variable. Ideally, for a stronger analysis, a healthy 
sample should be used to compare OA BMD with normal BMD to determine if there is a causal 
relationship between BMD and pain. In our precision analysis, there is a small sample of normal 
joints (n=7), showing trends of higher patellar BMD in healthy joints, but the sample is too small 
to perform powered statistical analysis. 
 Second, our clinical sample size was relatively small. Although 42 subjects, 21 in each 
group, was large enough to provide significant differences and is of similar group size with 
previous studies [33, 96, 97], it is too small to determine if changes in BMD were related to other 
confounding factors such as sex or BMI. However, as some of the observed differences were 
significant, sample sizes from this study could be used in power analysis for future work.  
 Third, a limitation of the CT-TOMASD technique is that the process is rather time-
consuming as each individual analysis takes about 20 to 25 minutes, with approximately 80% of 
the analysis time in the segmenting portion.  Although the process in the patella is less time 
consuming than previously reported in the tibia [23], it is still the rate limiting step. Automating 
segmenting would accelerate the analysis, and may also reduce precision errors. There is a small 
amount of manual editing during the segmenting process, in most cases close to the peripheral 
subchondral surface. Boundary point selection is also a manual process; although it is not time 
consuming, it does require a subjective user decision. Eliminating these manual portions could 
improve or prevent subjective user decision-making, improving reproducibility [128]. 
 
6.5. Conclusions 
1. CT-TOMASD can be confidently applied to the patella to measure subchondral cortical 
and trabecular bone density, with similar level of precision as previously reported at the 
tibia. Regional patellar CT-TOMASD precision errors ranged from 1.1% to 6.8% at depths 
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of 0-2.5mm, 1.2% to 5.0% at depths of 2.5-5mm and 1.6% to 5.1% at depths of 5-7.5mm in 
a sample of healthy and OA participants. Precision errors were many times smaller than 
observed density differences between patients with differing pain experiences (~4x 
smaller).  
2. Patellar subchondral BMD was lower in patients experiencing ‗severe pain at rest‘ in total 
lateral facet, particularly in the inferior lateral facet.  
a. Over the total lateral facet, patients experiencing ‗severe pain at rest‘ had 17% lower 
BMD at depth of 5-7.5mm than patients experiencing ‗non-severe pain at rest‘.   
b. Regionally, at the inferior lateral facet, patients experiencing ‗severe pain at rest‘ 
showed 13%, 23%, and 22% lower BMD at depths of 0-2.5mm, 2.5-5mm, and 5-
7.5mm depth respectively.  
 
6.6. Contributions 
This thesis research has generated many ‗firsts‘ (listed below) and has potential to change 
clinical BMD measurement from widely used 2D techniques (i.e., DXA) to 3D techniques (i.e., 
QCT).  
1. First study to simultaneously measure patellar subchondral cortical and trabecular BMD 
using clinical QCT.  
2. First application of CT-TOMASD technique to a sample of knees with clinically diagnosed 
OA. 
3. First reporting of relationships between regional localized patellar BMD and pain, 
specifically pain at rest, showing that individuals with ‗severe pain at rest‘ have lower 
BMD in deeper trabecular layers than individuals with ‗non-severe pain at rest‘.  
 
6.7. Clinical significance 
Current OA clinical measurement systems, such as the KL grade, use radiographic elements such 
as sclerosis, or regionally high BMD, to measure OA severity. In our clinical study we found that 
patients with more pain at rest actually had lower BMD—a measure not currently used to 
classify OA severity, or even detect presence of OA. This study suggests a previously 
unexplored clinical measure potentially linked to pain and OA severity.  
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 Current diagnostic tools are limited in detecting OA progression for optimal patient 
management. This could be due to limitations in current imaging tools or due to symptomatic 
presentation. CT-TOMASD is a clinical QCT-based tool having the potential to monitor small, 
localized BMD changes related to pain. It also has the ability to measure patient-specific BMD, 
and potentially monitor BMD changes in individuals prone to OA through longitudinal studies, 
helping to further explain the role of subchondral bone in the initiation and progression of OA. 
This research may provide insight into understanding bone-related OA pathophysiology, and 
may also provide insight into therapeutic targets, such as bone-modifying pharmaceuticals, and 
improving patient care and pain management.  
 
6.8. Future research 
1. For this study, we acquired images of the entire knee joint, including the proximal tibia and 
the distal femur. CT-TOMASD should be applied to the proximal tibia in this sample to 
determine if there are regional tibial BMD changes related to pain. 
2. The current CT-TOMASD program uses a projection ray technique, limiting it to 
measuring subchondral BMD at primarily flat or slightly concave surfaces such as the tibia 
and the patella. The image processing program could be modified to measure BMD 
patterns at the distal femur, using biplanar reconstruction [129] or curve-detection and 
surface normal technique permitting for CT-TOMASD analyses for distal femora.  
3. We can only hypothesize what the implications of lower BMD, in relation to pain, are 
related to the mechanical properties of bone. Preliminary finite element (FE) analyses in 
the proximal tibia showed that trabecular bone has the most dominant effect on structural 
stiffness [127]. There is a possibility that trabecular bone loss in regions with low BMD 
may be weak with higher flexibility, possibly leading to pain. We can test this hypothesis 
through application of finite element (FE) modeling in the patella, to determine how pain 
may be related to mechanical properties, such as bone strength, stiffness, and deformation, 
which can be estimated using BMD [7].  
4. The current study shows relationships between pain and BMD. We were not able to 
determine how BMD is affected by OA severity, or if other subchondral regions are 
affected. To overcome this, images could be collected from a healthy sample to use as a 
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baseline comparison. This set of normal joint scans could act as an independent variable 
and could help in possibly determining the causality of pain in relation to BMD.  
5. The CT-TOMASD segmenting process in the patella, although less intense than in the tibia, 
is still time consuming and involves some manual intervention and decision making on the 
part of the user. By automating the process, we could eliminate some of the subjective 
decision-making and possibly reduce precision errors [128], especially in peripheral 
regions. Also, by automating the segmentation process, it may provide more possibility to 
increase the CT-TOMASD user-base and apply this tool to longitudinal studies.  
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